Upfront Cost: Injections typically require lower initial payment but ongoing monthly expenses
SURMOUNT-4 showed 89.5% of patients maintained at least 80% of their weight loss with continued treatment
An additional concern is the capacity for an individual to properly break down and absorb the protein consumed
Surgery should be deferred when shedding remains active, weight or nutrition is unstable, the diagnosis is uncertain, inflammatory or scarring disease is active, donor miniaturization is diffuse, expectations are unrealistic, or the patient believes transplantation will stop future shedding
Because longterm safety data (especially for offlabel use) are limited, Better Med Spa screens thoroughly, avoids use in clients with active malignancy or uncontrolled metabolic disease, and monitors labs regularly